Key Findings

This is a quick summary of the main discovery for each research paper we have published, organized issue by issue. Each key finding is below the article title, with a link to the abstract. 


Search key findings View Previous Lists


Current List - November 2019

Association between opioid use disorder and fractures: a population‐based study

Taiwanese patients with opioid use disorder appear to have a higher risk of fracture than those without.

Link to Abstract

Behavioral economic tobacco demand in relation to cigarette consumption and nicotine dependence: a meta‐analysis of cross‐sectional relationships

Five demand indices derived from the cigarette purchase task were robustly associated with cigarette consumption and tobacco dependence, with maximum expenditure, intensity and elasticity exhibiting the strongest associations.

Link to Abstract

Buprenorphine prescribing for opioid use disorder in medical practices: can office‐based out‐patient care address the opiate crisis in the United States?

In US office‐based medical practices, diagnoses for opioid use disorder (OUD) and buprenorphine prescriptions for adults with OUD increased from 0.14 and 56.1% in 2006–10 to 0.38 and 73.6% in 2011–15.

Link to Abstract

Circumstances of death of opioid users being treated with naltrexone

The primary cause of death among people undergoing naltrexone treatment for opioid dependence in Australia from 2000 to 2017 was opioid toxicity.

Link to Abstract

Cytisine for nicotine addiction treatment: a review of pharmacology, therapeutics and an update of clinical trial evidence for smoking cessation

Cytisine is a low‐cost medication found to increase the likelihood of smoking cessation. The most frequent adverse reactions involve mild or moderate gastrointestinal symptoms.

Link to Abstract

Effectiveness of an offer of the Smoke Free smartphone application for smoking cessation: protocol for a randomized controlled trial

If it is effective, the Smoke Free smartphone app is an affordable and widely implementable intervention to help smokers to quit.

Link to Abstract

Elevated maternal and child mortality among women with multiple DUI convictions compared with socio‐demographically matched controls

Women having multiple convictions for driving under the influence of alcohol appears to be a risk factor for increased maternal, infant and child mortality.

Link to Abstract

Enhanced smoking cessation support for newly abstinent smokers discharged from hospital (the Hospital to Home trial): a randomized controlled trial

Home visits and continued support to prevent smoking relapse after hospital discharge did not appear to increase subsequent abstinence rate above usual care from NICE guidance.

Link to Abstract

Expenditure on smoking and alternative nicotine delivery products: a population survey in England

In England, the average smoker may save an estimated £15.06 per week by switching completely to e‐cigs or £13.04 per week by switching to NRT.

Link to Abstract

Mobile telephone‐delivered contingency management interventions promoting behaviour change in individuals with substance use disorders: a meta‐analysis

Mobile telephone‐delivered contingency management appears to reduce tobacco and alcohol use among adults not in treatment for substance use disorders.

Link to Abstract

Patterns and predictors of e‐cigarette, cigarette and dual use uptake in UK adolescents: evidence from a 24‐month prospective study

Higher impulsivity and having friends and family who smoke appear to predict adolescent smoking and/or e-cigarette use in the UK.

Link to Abstract

Predictors of long‐term abstinence rate by income level in the Korean smoking cessation programme

Lower income, and choice of bupropion versus varenicline are associated with lower chances of stopping smoking in Korean smoking cessation services and lower dependence is associated with higher success in low income smokers only.

Link to Abstract

Prescription opioid availability and opioid overdose‐related mortality rates in Medicaid expansion and non‐expansion states

In the wake of US Affordable Care Act Medicaid expansion, increases in prescription opioid availability do not appear to have mediated mortality rate increases, but there is still a possibility of lagged effects.

Link to Abstract

Psychostimulant use and the brain

The major neuropsychiatric harms of psychostimulant use can lead to severe long‐term impairment and include stroke, neurocognitive impairment, Parkinson's disease, seizures and psychotic illness.

Link to Abstract

The collectivity of British alcohol consumption trends across different temporal processes: a quantile age–period–cohort analysis

Countervailing drinking and alcohol‐related harm trends in the UK may be explained by lighter and heavier drinkers having different trends and the possibility of consumption rising in some age groups while falling in others.

Link to Abstract